Christopher H. Yaen

Array ( [id] => 299702 [patent_doc_number] => 07537901 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-26 [patent_title] => 'Extracellular serine protease' [patent_app_type] => utility [patent_app_number] => 11/295040 [patent_app_country] => US [patent_app_date] => 2005-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8166 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/537/07537901.pdf [firstpage_image] =>[orig_patent_app_number] => 11295040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5074833 [patent_doc_number] => 20070014808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Polypeptide' [patent_app_type] => utility [patent_app_number] => 11/286056 [patent_app_country] => US [patent_app_date] => 2005-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 18969 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20070014808.pdf [firstpage_image] =>[orig_patent_app_number] => 11286056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5721248 [patent_doc_number] => 20060074023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Angiogenesis associated proteins, and nucleic acids encoding the same' [patent_app_type] => utility [patent_app_number] => 11/285818 [patent_app_country] => US [patent_app_date] => 2005-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52711 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20060074023.pdf [firstpage_image] =>[orig_patent_app_number] => 11285818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5637468 [patent_doc_number] => 20060068441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Alternative pol kappa nucleotide and amino acid sequence and methods for using' [patent_app_type] => utility [patent_app_number] => 11/274658 [patent_app_country] => US [patent_app_date] => 2005-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16961 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20060068441.pdf [firstpage_image] =>[orig_patent_app_number] => 11274658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5710006 [patent_doc_number] => 20060051351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'ErbB4 receptor-specific neuregulin related ligands and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/256548 [patent_app_country] => US [patent_app_date] => 2005-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 33256 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051351.pdf [firstpage_image] =>[orig_patent_app_number] => 11256548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5766833 [patent_doc_number] => 20060018914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Novel antibody conjugates reactive with human carcinomas' [patent_app_type] => utility [patent_app_number] => 11/223680 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 74 [patent_figures_cnt] => 74 [patent_no_of_words] => 51778 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20060018914.pdf [firstpage_image] =>[orig_patent_app_number] => 11223680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5759632 [patent_doc_number] => 20060210577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'RTVP-GliPR-like compositions and methods for the detection, treatment and prevention of prostate cancer' [patent_app_type] => utility [patent_app_number] => 11/217067 [patent_app_country] => US [patent_app_date] => 2005-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12504 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20060210577.pdf [firstpage_image] =>[orig_patent_app_number] => 11217067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6977870 [patent_doc_number] => 20050287588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Breast cancer specific gene 1' [patent_app_type] => utility [patent_app_number] => 11/205031 [patent_app_country] => US [patent_app_date] => 2005-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16642 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287588.pdf [firstpage_image] =>[orig_patent_app_number] => 11205031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5814800 [patent_doc_number] => 20060084603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'IGF-BP3-related methods for inhibiting tumor growth' [patent_app_type] => utility [patent_app_number] => 11/197874 [patent_app_country] => US [patent_app_date] => 2005-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14183 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084603.pdf [firstpage_image] =>[orig_patent_app_number] => 11197874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 840541 [patent_doc_number] => 07390871 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-24 [patent_title] => 'Tumor antigen based on products of the tumor suppressor gene WT1' [patent_app_type] => utility [patent_app_number] => 11/196459 [patent_app_country] => US [patent_app_date] => 2005-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 4974 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/390/07390871.pdf [firstpage_image] =>[orig_patent_app_number] => 11196459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 221139 [patent_doc_number] => 07608685 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-10-27 [patent_title] => 'Tumor antigen based on products of the tumor suppressor gene WT1' [patent_app_type] => utility [patent_app_number] => 11/196452 [patent_app_country] => US [patent_app_date] => 2005-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 4982 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/608/07608685.pdf [firstpage_image] =>[orig_patent_app_number] => 11196452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7243608 [patent_doc_number] => 20050271665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Methods of inhibiting metastasis' [patent_app_type] => utility [patent_app_number] => 11/197711 [patent_app_country] => US [patent_app_date] => 2005-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10337 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20050271665.pdf [firstpage_image] =>[orig_patent_app_number] => 11197711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 91675 [patent_doc_number] => 07732131 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Therapeutic and diagnostic methods and compositions targeting 4Ig-B7-H3 and its counterpart NK cell receptor' [patent_app_type] => utility [patent_app_number] => 11/659175 [patent_app_country] => US [patent_app_date] => 2005-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 39678 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732131.pdf [firstpage_image] =>[orig_patent_app_number] => 11659175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6930774 [patent_doc_number] => 20050281808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Peptide fragments having cell death-inhibitory activity' [patent_app_type] => utility [patent_app_number] => 11/185859 [patent_app_country] => US [patent_app_date] => 2005-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12136 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20050281808.pdf [firstpage_image] =>[orig_patent_app_number] => 11185859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6930777 [patent_doc_number] => 20050281811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Anti-lymphotoxin-beta receptor antibodies as anti-tumor agents' [patent_app_type] => utility [patent_app_number] => 11/185373 [patent_app_country] => US [patent_app_date] => 2005-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14776 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20050281811.pdf [firstpage_image] =>[orig_patent_app_number] => 11185373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7182720 [patent_doc_number] => 20050191285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated' [patent_app_type] => utility [patent_app_number] => 11/121347 [patent_app_country] => US [patent_app_date] => 2005-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13081 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191285.pdf [firstpage_image] =>[orig_patent_app_number] => 11121347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5771611 [patent_doc_number] => 20050267062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Regulation of angiogenesis with zinc finger proteins' [patent_app_type] => utility [patent_app_number] => 11/115922 [patent_app_country] => US [patent_app_date] => 2005-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 45318 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20050267062.pdf [firstpage_image] =>[orig_patent_app_number] => 11115922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5767648 [patent_doc_number] => 20060019310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Cell regulatory genes, encoded products, and uses related thereto' [patent_app_type] => utility [patent_app_number] => 11/109831 [patent_app_country] => US [patent_app_date] => 2005-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 53484 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019310.pdf [firstpage_image] =>[orig_patent_app_number] => 11109831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5743121 [patent_doc_number] => 20060088846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Methods to identify compounds useful for the treatment of proliferative and differentiative disorders' [patent_app_type] => utility [patent_app_number] => 11/106014 [patent_app_country] => US [patent_app_date] => 2005-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 136 [patent_figures_cnt] => 136 [patent_no_of_words] => 56401 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088846.pdf [firstpage_image] =>[orig_patent_app_number] => 11106014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 161701 [patent_doc_number] => 07670599 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-02 [patent_title] => 'YKL-40 as a marker and prognostic indicator for cancers' [patent_app_type] => utility [patent_app_number] => 11/073333 [patent_app_country] => US [patent_app_date] => 2005-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 32940 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/670/07670599.pdf [firstpage_image] =>[orig_patent_app_number] => 11073333 [rel_patent_id] =>[rel_patent_doc_number] =>)